Javier F.
- Country
- Spain
- Department
- Alergology
Research Overview
- Randomized, Double‑Blind, Placebo‑Controlled Trial of Subcutaneous HDM (Dermatophagoides pteronyssinus, D. farinae) and Blomia tropicalis Extract in Allergic Rhinitis
- Evaluation of Subcutaneous Immunotherapy with Der p 1/Der p 2/Der p 23 Allergens in Moderate/Severe Allergic Rhinitis/Rhinoconjunctivitis with/without Controlled Allergic Asthma
Data & Insights
Has run more than one trial at 2 of 15 partner sites.
Specializations
Allergic Conditions
The investigator specializes in treating allergic rhinitis and rhinoconjunctivitis, with particular focus on cases related to Dermatophagoides genus sensitization.
- Moderate to severe allergic respiratory conditions
- House dust mite allergies
- Combined allergic manifestations
Clinical expertise extends to managing patients with controlled allergic asthma in combination with upper respiratory allergies.
Immunotherapy
The investigator focuses on advancing subcutaneous immunotherapy treatments, particularly exploring innovative combinations of allergen components including Der p 1, Der p 2, and Der p 23.
- Allergen-specific immunotherapy
- Dose optimization studies
- Long-term maintenance therapy
Expertise in evaluating therapeutic responses through extended maintenance treatment protocols.
Therapeutic Assessment
The investigator specializes in comprehensive benefit-risk assessment of immunotherapy treatments for allergic conditions.
- Safety evaluation protocols
- Treatment efficacy assessment
- Clinical response monitoring
Focus on determining optimal therapeutic doses for sustained treatment effectiveness in allergic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.